Head-to-head comparison
Ivy Rx vs Rx.com
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Telehealth provider offering tiered compounded semaglutide and tirzepatide programs.
From $175/mo (lowest dose rung) sema · From $275/mo (lowest dose rung) tirz · Verified July 2026
Marked down on: Limited public information on program details
Desk Score
Names the pharmacy that fills the vial, with a street address, and prints "No automatic renewals" on the plan card — then advertises another drug's prepay rate.
$175/mo sema · $285/mo tirz · Verified September 2026
Marked down on: The advertised "$146/mo FOR LIFE" is a six-month prepay on semaglutide; month-to-month tirzepatide is $285.
Rx.com takes this head-to-head with the higher Desk Score, 78/100 (C+) against 77/100 (C+) for Ivy Rx. Ivy Rx still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Ivy Rx
77/100
C+
Rx.com
78/100
C+
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Ivy Rx | Rx.com |
|---|---|---|
| Semaglutide | From $175/molowest dose rung$175/mo (starting dose, compounded) | $175/mo$175/mo month-to-month (compounded; $146 only on a 6-month prepay) |
| Tirzepatide | From $275/molowest dose rung$275/mo (starting dose, compounded) | $285/mo$285/mo month-to-month (compounded; $259 only on a 6-month prepay) |
| Coverage | All 50 states | 49 states (its own banner says all 50) |
| Brand-name | Compounded only | Compounded only |
| Oral option | Injectable only | Injectable only |
| Best for | Mainstream telehealth GLP-1 access. | Someone who will judge it by the plan card rather than the banner, and who wants no auto-renewal and a named pharmacy. |
| Desk Score | 77/100C+ | 78/100C+ |
The verdict
Desk pick — Rx.comRx.com takes this head-to-head with the higher Desk Score, 78/100 (C+) against 77/100 (C+) for Ivy Rx. Ivy Rx still holds its ground where its strengths line up with yours.
Choose Ivy Rx if…
Mainstream telehealth GLP-1 access.
From $175/mo (lowest dose rung) sema · From $275/mo (lowest dose rung) tirz · All 50 states
Choose Rx.com if…
Someone who will judge it by the plan card rather than the banner, and who wants no auto-renewal and a named pharmacy.
$175/mo sema · $285/mo tirz · 49 states (its own banner says all 50)
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: Ivy Rx · Rx.com.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- CoreAge Rx vs Ivy Rx
- CoreAge Rx vs Rx.com
- Ivy Rx vs Strut Health
- Rx.com vs Trimi
- Ivy Rx vs Trimi
- Elara Health and Wellness vs Rx.com
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.